5,14-Ethanoindolo[2',3':3,4]pyrido[1,2-g]-1,6- naphthyridine,1,2,3,4,4a,5,7,8,13,13b,14,14adodecahydro-,(4aR,5R,13bS,14S,14aS)- (57969-03-6)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 5,14-Ethanoindolo[2',3':3,4]pyrido[1,2-g]-1,6-naphthyridine,1,2,3,4,4a,5,7,8,14,14a-decahydro-, (4aR,5R,14S,14aS)-
- 1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H
- 1/C15H13NO/c1-2-16-14-6-4-3-5-12(14)13-9-11(10-17)7-8-15(13)16/h3-10H,2H2,1H
- 1/C11H7ClO2/c12-9-3-1-2-8(6-9)11-5-4-10(7-13)14-11/h1-7
- 1/C15H18N2O/c18-15-12-7-3-2-6-11(12)14-16-13-8-4-1-5-10(13)9-17(14)15/h2-3,6-7,10,13-14,16H,1,4-5,8-9H2/t10-,13-,14-/m1/s
- 1/C7H10N3O3P/c1-4-7-13-9-5(2)14(7,12)10(8-4)6(3)11/h7H,1-3H
- 1/C13H15NO2/c15-8-10-7-9-3-1-5-14-6-2-4-11(12(9)14)13(10)16/h7-8,16H,1-6H
- 1/C14H12NS/c1-2-6-12(7-3-1)10-15-11-16-14-9-5-4-8-13(14)15/h1-9,11H,10H2/q+
- 1/C14H9Br2O2P/c15-11-6-8-13(17-11)19(10-4-2-1-3-5-10)14-9-7-12(16)18-14/h1-9
- 1/C12H24O2Te/c1-14-12(13)10-8-6-4-3-5-7-9-11-15-2/h3-11H2,1-2H
- 1/C14H19NO2/c1-3-12-10-17-9-8-15(12)14-7-5-4-6-13(14)11(2)16/h4-7,12H,3,8-10H2,1-2H
- 1/C11H14N2O6/c1-17-7(14)4-12-2-3-13-9(10(12)15)8-6(19-13)5-18-11(8)16/h6,8-9H,2-5H2,1H
- 4H,13aH-4a,13-Ethano-5,13-methano-10H-1,- 3-dioxolo[4,5-g]indolizino[2',1':2,3]pyrano[4,3- b]indole-4-carboxylic acid,5,6,7a,8,11,12-hexahydro-5-hydroxy-6,- 8-dioxo-,methyl ester,(4aS,5S,7aR,13R,13aS,13bS)-
- 1/C13H10O/c14-13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)13/h1-8,13-14
- 1/C13H9IO2/c15-13-11-8-4-5-9-12(11)14(16-13)10-6-2-1-3-7-10/h1-9
- 1/C15H11Br/c16-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)15/h1-9H,10H
- 1/C12H13NO/c1-2-4-10(5-3-1)13-11-6-8-12(14-13)9-7-11/h1-6,8,11-12H,7,9H
- 1/C13H19NO2/c1-9(15)6-7-10-8-13(16-14-10)11-4-2-3-5-12(11)13/h11-12H,2-8H2,1H
- Indolo[2',3':3,4]pyrido[1,2-b][2,7]naphthyridine-1-carboxylicacid, 3,4,4a,5,7,8,13,13b,14,14a-decahydro-4-methyl-, methyl ester,(4S,4aS,13bS,14aS)-
- 1/C15H18O2/c1-11(16)6-7-12-4-3-5-13-10-14(17-2)8-9-15(12)13/h4,8-10H,3,5-7H2,1-2H